BAILLIE GIFFORD & CO – Ionis Pharmaceuticals, Inc. Transaction History
BAILLIE GIFFORD & CO portfolio value:
$14.36M
portfolio value
BAILLIE GIFFORD & CO quarter portfolio value change:
+19.48%
quarter
Ionis Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +4.45% | 13.82K shares | 2.85M | $44.23 | 324.84K |
| Q2 2022 | share | Decrease | -10.85% | -37.84K shares | -1.40M | $37.02 | 311.01K |
| Q1 2022 | share | Increase | +10.46% | 33.04K shares | 3.31M | $37.04 | 348.86K |
| Q4 2021 | share | Increase | +4.58% | 13.81K shares | -518K | $30.54 | 315.82K |
| Q3 2021 | share | Increase | +11.28% | 30.60K shares | -697K | $33.54 | 302.00K |
| Q2 2021 | share | Increase | +14.05% | 33.43K shares | 127K | $39.89 | 271.39K |
| Q1 2021 | share | Increase | +88.53% | 111.74K shares | 3.56M | $44.96 | 237.95K |
| Q4 2020 | share | Decrease | -97.44% | -4.79M shares | -226.35M | $56.54 | 126.21K |
| Q3 2020 | share | Decrease | -40.13% | -3.29M shares | -251.08M | $47.45 | 4.92M |
| Q2 2020 | share | Decrease | -6.03% | -526.98K shares | 71.07M | $58.96 | 8.21M |
| Q1 2020 | share | Decrease | -0.50% | -44.34K shares | -117.51M | $47.28 | 8.74M |
| Q4 2019 | share | Increase | +4.45% | 374.73K shares | 26.84M | $60.41 | 8.79M |
| Q3 2019 | share | Decrease | -0.34% | -28.96K shares | -38.55M | $59.91 | 8.41M |
| Q2 2019 | share | Decrease | -2.31% | -200.10K shares | -158.95M | $64.27 | 8.44M |
| Q1 2019 | share | Decrease | -1.21% | -105.66K shares | 228.63M | $81.17 | 8.64M |
| Q4 2018 | share | Decrease | -2.32% | -208.09K shares | 10.96M | $54.06 | 8.75M |
| Q3 2018 | share | Decrease | -3.47% | -321.61K shares | 75.37M | $51.58 | 8.95M |
| Q2 2018 | share | Increase | +48.18% | 3.01M shares | 110.63M | $41.67 | 9.27M |
| Q1 2018 | share | Decrease | -5.29% | -349.65K shares | -56.54M | $44.08 | 6.26M |
| Q4 2017 | share | Decrease | -5.11% | -355.84K shares | -20.68M | $50.3 | 6.61M |
| Q3 2017 | share | Decrease | -6.45% | -480.23K shares | -25.61M | $50.7 | 6.96M |
| Q2 2017 | share | Decrease | -4.69% | -366.41K shares | 64.74M | $50.87 | 7.44M |
| Q1 2017 | share | Decrease | -7.13% | -600.35K shares | -88.34M | $40.2 | 7.81M |
| Q4 2016 | share | Decrease | -0.71% | -60.19K shares | 91.96M | $47.83 | 8.41M |
| Q3 2016 | share | Decrease | -2.17% | -188.36K shares | 108.75M | $36.64 | 8.47M |
| Q2 2016 | share | Increase | +4.59% | 379.97K shares | -133.71M | $23.29 | 8.66M |
| Q1 2016 | share | Increase | +2.54% | 205.22K shares | -164.81M | $40.5 | 8.28M |